Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study
Background: In the UK, juvenile idiopathic arthritis is the most common inflammatory disorder in childhood, affecting 10 : 100,000 children and young people aged < 16 years each year, with a population prevalence of around 1 : 1000. Corticosteroids are commonly used to treat juvenile idiopathic a...
Main Authors: | Ashley P Jones, Dannii Clayton, Gloria Nkhoma, Frances C Sherratt, Matthew Peak, Simon R Stones, Louise Roper, Bridget Young, Flora McErlane, Tracy Moitt, Athimalaipet V Ramanan, Helen E Foster, Paula R Williamson, Samundeeswari Deepak, Michael W Beresford, Eileen M Baildam |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2020-07-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta24360 |
Similar Items
-
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials
by: Frances C. Sherratt, et al.
Published: (2018-12-01) -
Where Is Pediatric Rheumatology Going, and Why a New Section of Frontiers in Pediatrics?
by: Rolando Cimaz
Published: (2020-06-01) -
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
by: Athimalaipet V. Ramanan, et al.
Published: (2018-02-01) -
Mia Alessandra : life with Juvenile Idiopathic Arthritis
by: Sherry, Grace Carolyn
Published: (2013) -
Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis
by: William D. Renton, et al.
Published: (2019-10-01)